Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2396 (LINC02396) is a human long non-coding RNA gene. It encodes an RNA transcript longer than 200 nucleotides that does not overlap annotated coding genes, and is classified as a long intergenic non-coding RNA (lincRNA)[1][3]. The biological function, molecular interactions, and involvement in disease are currently unknown. LINC02396 does not encode a protein and is not a receptor, enzyme, or transporter. While lincRNAs as a class can have diverse functions such as gene regulation, chromatin remodeling, or cellular signaling, there is no published evidence for any specific role, disease association, or therapeutic targeting for LINC02396[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2396 (LINC02396).